AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Sustanon

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 23 USDMF, 9 CEP/COS, 15 EU WC, 48 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers, 60 FDA Orange Book, 39 Europe, 7 Canada, 8 Australia, 6 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION, GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION, GEL;TRANSDERMAL - 25MG/2.5GM PACKET, GEL;TRANSDERMAL - 50MG/5GM PACKET, GEL;TRANSDERMAL - 50MG/5GM PACKET, TABLET, EXTENDED RELEASE;BUCCAL - 30MG, GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION), GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET), SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 SPI Pharma, 4 DKSH, 6 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 BioSpectra, 2 Clariant, 15 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Lubrizol Life Science Health, 14 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 36 Topical, 29 Controlled & Modified Release, 26 Thickeners and Stabilizers, 23 Direct Compression, 21 Granulation, 18 Lubricants & Glidants, 18 Disintegrants & Superdisintegrants, 16 Film Formers & Plasticizers, 15 Solubilizers, 14 Co-Processed Excipients, 12 Parenteral, 7 Taste Masking, 6 API Stability Enhancers, 6 Emulsifying Agents, 6 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

121 News #PharmaBuzz

121 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 36 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

37 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

10 EDQM, 1 USP, 6 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
30/12/2024	Aspen API	Netherlands	Aspen Oss B.V.	60870-0251	Testosterone	1980-04-25	2025-12-31	BULK INGREDIENT	POWDER (1g/g)
30/12/2024	Symbiotec Pharmalab	India	Symbiotec Pharmalab Private Limited	22552-0009	Testosterone	2010-04-29	2025-12-31	BULK INGREDIENT	POWDER (1g/g)

Sustanon

Sustanon

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

62 API Suppliers

23 USDMF

9 CEP/COS

15 EU WC

48 NDC API

34 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers

60 FDA Orange Book

39 Europe

7 Canada

8 Australia

6 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION

GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION

GEL;TRANSDERMAL - 25MG/2.5GM PACKET

GEL;TRANSDERMAL - 50MG/5GM PACKET

GEL;TRANSDERMAL - 50MG/5GM PACKET

TABLET, EXTENDED RELEASE;BUCCAL - 30MG

GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION)

GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET)

SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 SPI Pharma

4 DKSH

6 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

7 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

23 BASF

1 BioSpectra

2 Clariant

15 Corel Pharma Chem

6 DFE Pharma

2 Finar

7 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

7 Lubrizol Life Science Health

14 Microlex e.U

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons